RBP4 is recognized as a negative acute inflammatory reactant and as a novel adipokine, whose levels increase in insulin-resistant conditions, such as obesity, metabolic syndrome, type 2 diabetes mellitus [45], as well as cardiovascular diseases [46]. The gene discussed is RBP4; the disease is obesity due to melanocortin 4 receptor deficiency.